Researchers have been excited about this new drug, a groundbreaking dual treatment showing significant outcomes in early trials for size management. It acts by modulating both systems: GLP-1 and GIP, these, when activated , help influence appetite and enhance calorie burn. Preliminary findings demonstrate noteworthy size reduction and potential ben